![webinar videos](/sg/sites/default/files/2024-01/webinar%20videos.jpg)
WEBINAR VIDEOS
Document ID: PC-MY-102220
Speaker: Prof. Jin-Hyoung Kang
Taking Cancer On Webinar – Let’s TOAST to Maximising Time on EGFR-TKI Therapy (Lecture)
Watch Prof. Jin-Hyoung Kang as he discusses how sequential approach with upfront GIOTRIF® (afatinib) is a feasible and cost-effective treatment strategy for EGFR M+ NSCLC patients.
Speaker
![Prof-Jin-Hyoung-Kang-Image Prof-Jin-Hyoung-Kang-Image](/sg/sites/default/files/2024-01/Prof-Jin-Hyoung-Kang-Image.png)
Prof. Jin-Hyoung Kang
Professor of Medicine, Seoul St. Mary’s Hospital
Director in Medical Oncology Program, The Catholic University of Korea
Seoul, South Korea